2 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
Follow Low Bone Mass: new trials by email Literature Review of Low Bone Mass trials Research Report on Low Bone Mass
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Compare the Efficacy and Safety of DenosumAb Versus Placebo in Males With Osteoporosis 60 mg denosumab, Placebo - Low Bone Mass, Low Bone Mineral Density | Phase 3 | Completed | Amgen | 242 | 2009-10-01 | 2018-10-17 |
| A High-resolution Peripheral Quantitative Computed Tomography Study in Postmenopausal Women Previously Treated With Denosumab high-resolution peripheral quantitative computed tomography (HR-pQCT), Dual energy X-ray absorptiometry (DXA), Denosumab - Low Bone Mass, Low Bone Mineral Density | Phase 3 | Completed | Amgen | 79 | 2009-07-01 | 2014-04-02 |
Bone Diseases, Metabolic (2) · Osteoporosis (2) · Multiple Endocrine Neoplasia Type 1 (1) · Osteoporosis, Postmenopausal (1)
Bone Diseases (2) · Metabolic Diseases (2) · Musculoskeletal Diseases (2) · Nutritional and Metabolic Diseases (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1) · Genetic Diseases, Inborn (1) · Multiple Endocrine Neoplasia (1) · Neoplasms (1) · Neoplasms by Site (1) · Neoplasms, Multiple Primary (1) · Neoplastic Syndromes, Hereditary (1)
Denosumab (2) · Absorptiometry, Photon (1)
Amgen (2)